Matches in Wikidata for { <http://www.wikidata.org/entity/Q66028224> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q66028224 description "clinical trial" @default.
- Q66028224 description "ensayu clínicu" @default.
- Q66028224 description "klinisch onderzoek" @default.
- Q66028224 description "клінічне випробування" @default.
- Q66028224 name "A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)" @default.
- Q66028224 name "A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)" @default.
- Q66028224 type Item @default.
- Q66028224 label "A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)" @default.
- Q66028224 label "A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)" @default.
- Q66028224 prefLabel "A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)" @default.
- Q66028224 prefLabel "A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)" @default.
- Q66028224 P1132 Q66028224-E4795763-AECB-4C4D-99E3-45375237DCA7 @default.
- Q66028224 P1476 Q66028224-82CC0C22-2B4A-4106-8A21-E302BAB0DE3D @default.
- Q66028224 P2899 Q66028224-666BF3A4-03CC-40F0-8351-53573D02BDE0 @default.
- Q66028224 P3098 Q66028224-48B33121-4001-4E37-9CD7-A9DC8CA0E449 @default.
- Q66028224 P31 Q66028224-AEE3D9C0-7456-47D1-B758-581EBC24A16F @default.
- Q66028224 P4844 Q66028224-BE433418-0C80-4C7A-B4EA-F31D66A1A6B7 @default.
- Q66028224 P580 Q66028224-09314E41-FF4B-4640-85ED-DA74BDF2D2FB @default.
- Q66028224 P582 Q66028224-ADBA3117-F474-4185-9E0A-8C76F77E890D @default.
- Q66028224 P6099 Q66028224-38A4B765-096D-4480-9AC3-CAC434068F95 @default.
- Q66028224 P8363 Q66028224-C17D44C1-6E5D-4A2E-AD2B-DD8B88A6CAD0 @default.
- Q66028224 P1132 "+604" @default.
- Q66028224 P1476 "A Phase III Multi-national, Multi-centre, Double-blind Placebo-controlled Parallel Group, 26 Week Study to Assess the Safety and Efficacy of the Humanised Anti-TNF PEG Conjugate, CDP870 400 mg sc, (Dosed at Weeks 0, 2, 4 Then 4-weekly to Week 24), in the Treatment of Patients With Active Crohn's Disease" @default.
- Q66028224 P2899 "+18" @default.
- Q66028224 P3098 "NCT00152490" @default.
- Q66028224 P31 Q30612 @default.
- Q66028224 P4844 Q412909 @default.
- Q66028224 P580 "2003-12-01T00:00:00Z" @default.
- Q66028224 P582 "2005-05-01T00:00:00Z" @default.
- Q66028224 P6099 Q42824827 @default.
- Q66028224 P8363 Q78089383 @default.